---
figid: PMC5593081__nihms900761f2
figlink: /pmc/articles/PMC5593081/figure/F2/
number: Figure 2
caption: Recognition of pathogen-associated molecular patterns (PAMPs) or danger-associated
  molecular patterns (DAMPs) by inflammasome-initiating sensors leads to the activation
  of the inflammasome and initiation of pyroptosis and release of the bioactive form
  of IL-1β and IL-18 (). IL-1β and IL-18 engage in autocrine and paracrine signaling
  pathways via the IL-1 receptor (IL-1R) and IL-18 receptor (IL-18R), respectively.
  The inflammasome signaling pathway can be inhibited by pharmacological inhibition
  of activation of the inflammasome (Parthenolide, MCC950, Glyburide, and BAY-11–7082)
  (–), ASC oligomerization (CRID3) (), caspase-1 (Thalidomide and Belnacasan or VX-765)
  (,), and IL-1R (Anakinra or Kineret, and Rilonacept or Arcalyst) (,), or neutralizing
  IL-1β (Canakinumab or Ilaris) () or IL-18 (IL-18 binding proteins or IL-18BP) ().
pmcid: PMC5593081
papertitle: Inflammasomes and Cancer.
reftext: Rajendra Karki, et al. Cancer Immunol Res. ;5(2):94-99.
pmc_ranked_result_index: '14575'
pathway_score: 0.9359196
filename: nihms900761f2.jpg
figtitle: Inflammasomes and Cancer
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5593081__nihms900761f2.html
  '@type': Dataset
  description: Recognition of pathogen-associated molecular patterns (PAMPs) or danger-associated
    molecular patterns (DAMPs) by inflammasome-initiating sensors leads to the activation
    of the inflammasome and initiation of pyroptosis and release of the bioactive
    form of IL-1β and IL-18 (). IL-1β and IL-18 engage in autocrine and paracrine
    signaling pathways via the IL-1 receptor (IL-1R) and IL-18 receptor (IL-18R),
    respectively. The inflammasome signaling pathway can be inhibited by pharmacological
    inhibition of activation of the inflammasome (Parthenolide, MCC950, Glyburide,
    and BAY-11–7082) (–), ASC oligomerization (CRID3) (), caspase-1 (Thalidomide and
    Belnacasan or VX-765) (,), and IL-1R (Anakinra or Kineret, and Rilonacept or Arcalyst)
    (,), or neutralizing IL-1β (Canakinumab or Ilaris) () or IL-18 (IL-18 binding
    proteins or IL-18BP) ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1R1
  - IL1B
  - IL18BP
  - IL18
  - PYCARD
  - Parthenolide
  - BAY-11-7082
  - Glyburide
  - Thalidomide
genes:
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-18BP
  symbol: IL18BP
  source: hgnc_symbol
  hgnc_symbol: IL18BP
  entrez: '10068'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: ASC
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
chemicals:
- word: Parthenolide
  source: MESH
  identifier: C002669
- word: BAY-11-7082
  source: MESH
  identifier: C434003
- word: Glyburide
  source: MESH
  identifier: D005905
- word: Thalidomide
  source: MESH
  identifier: D013792
diseases: []
---
